ADAGIO MEDICAL HOLDINGS, INC. Net Income (Loss) Available to Common Stockholders, Diluted
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$6.72 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-11
- ADAGIO MEDICAL HOLDINGS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was -$6.72M.
- ADAGIO MEDICAL HOLDINGS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was -$7.00M.
- ADAGIO MEDICAL HOLDINGS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was -$3.31M.
- ADAGIO MEDICAL HOLDINGS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was -$10.12M.
- ADAGIO MEDICAL HOLDINGS, INC. net income (loss) available to common stockholders, diluted for fiscal 2025 was -$25.08M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 1 month | Net Income (Loss) Available to Common Stockholders, Diluted 2 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 5 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 7 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.72M 10-Q · filed 2026-08-11 | -$13.71M 10-Q · filed 2026-08-11 | -$17.02M derived: sum of 3 quarters · filed 2026-08-11 | -$27.14M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | -$7.00M 10-Q · filed 2026-05-12 | -$10.30M derived: sum of 2 quarters · filed 2026-05-12 | -$20.42M derived: sum of 3 quarters · filed 2026-05-12 | -$25.79M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | -$3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$13.42M derived: sum of 2 quarters · filed 2026-03-27 | -$18.80M derived: sum of 3 quarters · filed 2026-08-11 | -$25.08M 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | -$10.12M 10-Q · filed 2025-11-12 | -$15.49M derived: sum of 2 quarters · filed 2026-08-11 | -$21.78M 10-Q · filed 2025-11-12 | |||||
| 2025-06-30 | -$5.37M 10-Q · filed 2026-08-11 | -$13.28M 10-Q · filed 2026-08-11 | ||||||
| 2025-03-31 | -$7.90M 10-Q · filed 2026-05-12 | |||||||
| 2024-12-31 | -$54.69M 10-K · filed 2026-03-27 | |||||||
| 2024-09-30 | $351.00K 10-Q · filed 2024-11-14 | |||||||
| 2024-07-30 | -$8.23M 10-Q · filed 2024-11-14 | -$21.28M 10-K · filed 2026-03-27 | ||||||
| 2023-09-30 | -$27.97M 10-Q · filed 2024-11-14 | |||||||
| 2023-07-30 | -$10.76M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |